Journal article
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Clinical Chemistry · 2018
Bibliographic details
Source record
Langlois MR, Chapman MJ, Cobbaert C Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM. 64(7). 1006-1033.
DOI PMID: 29760220 Open original source
Where this source appears